Skip to content

Search

Showing results for "aboriginal respiratory"

Warajanga marnti warranja – together we walk on country

A $5 million commitment from BHP has allowed The Kids researchers and Aboriginal communities to make FASD history in the Pilbara.

The Kids researchers honoured at Premier’s Science Awards

A The Kids Research Institute Australia researcher devoted to Aboriginal health and justice has been named the inaugural Shell Aboriginal STEM Student of the Year at the 2019 Premier’s Science Awards.

Footprints in Time: the Longitudinal Study of Indigenous Children

This report and series of fact sheets explore findings from Waves 11 and 12 of the Footprints in Time, the Longitudinal Study of Indigenous Children.

Systematic review of the evidence for treatment and management of common skin conditions in resource-limited settings: An update

The skin is the largest and most visible organ of the human body. As such, skin infections can have a significant impact on overall health, social wellbeing and self-image. 

Four The Kids Research Institute Australia research leaders named as finalists for West Australian of the Year Awards

Four outstanding members of The Kids Research Institute Australia family have been named as finalists in the 2024 Western Australian of the Year Awards.

Community collaboration ensures ending RHD is everybody’s business

Collaboration is the driving force behind ‘END RHD Demonstration Communities’ – a new community-driven, research-backed approach to tackling rheumatic heart disease (RHD) in remote Australia.

Leveraging global lung health expertise to help preterm bubs

The world’s leading preterm scientists and doctors have joined forces to help give babies born very prematurely, the best possible life.

Researchers may have found key to preventing asthma

Researchers have made a world-first discovery on how to prevent severe respiratory infections in babies.

AI-Driven Cell Tracking to Enable High-Throughput Drug Screening Targeting Airway Epithelial Repair for Children with Asthma

The airway epithelium of children with asthma is characterized by aberrant repair that may be therapeutically modifiable. The development of epithelial-targeting therapeutics that enhance airway repair could provide a novel treatment avenue for childhood asthma.

Azithromycin inhibits mucin secretion, mucous metaplasia, airway inflammation, and airways hyperresponsiveness in mice exposed to house dust mite extract

Excessive production, secretion, and retention of abnormal mucus is a pathological feature of many obstructive airways diseases including asthma. Azithromycin is an antibiotic that also possesses immunomodulatory and mucoregulatory activities, which may contribute to the clinical effectiveness of azithromycin in asthma.